Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

6.11
Delayed Data
As of May 02
 +0.11 / +1.83%
Today’s Change
3.50
Today|||52-Week Range
17.87
-15.14%
Year-to-Date
No recent news for InVivo Therapeutics Holdings Corp.

Today’s Trading

Previous close6.00
Today’s open6.07
Day’s range5.93 - 6.15
Volume234,316
Average volume (3 months)401,479
Market cap$191.4M
Dividend yield--
Data as of 05/02/2016

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-85.88%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book9.77

Competitors

 Today’s
change
Today’s
% change
AVXLAnavex Life Sciences...-0.22-4.03%
PRTOProteon Therapeutics...-0.06-0.61%
FLXNFlexion Therapeutics...+0.23+2.21%
ENZEnzo Biochem Inc+0.05+1.00%
Data as of 05/02/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$0.00
Annual profit (last year)-$33.3M
Net profit margin--

Profile

Sector
Industrial Services
Industry
Engineering & Construction
Chairman &
Chief Executive Officer
Mark D. Perrin
Senior Vice President-
Operations
William D'Agostino
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs